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Hypoglycemia-activated 
Hypothalamic Microglia Impairs 
Glucose Counterregulatory 
Responses
Zsuzsanna Winkler1,2, Dániel Kuti1,2, Ágnes Polyák1, Balázs Juhász1,2, Krisztina Gulyás  1, 
Nikolett Lénárt1,3, Ádám Dénes1,3, Szilamér Ferenczi1 & Krisztina J. Kovács1
Glucose is a major fuel for the central nervous system and hypoglycemia is a significant homeostatic 
stressor, which elicits counterregulatory reactions. Hypothalamic metabolic- and stress-related 
neurons initiate these actions, however recruitment of glia in control such adaptive circuit remain 
unknown. Groups of fed- and fasted-, vehicle-injected, and fasted + insulin-injected male mice 
were compared in this study. Bolus insulin administration to fasted mice resulted in hypoglycemia, 
which increased hypothalamo-pituitary-adrenal (HPA) axis- and sympathetic activity, increased 
transcription of neuropeptide Y (Npy) and agouti-related peptide (Agrp) in the hypothalamic arcuate 
nucleus and activated IBA1+ microglia in the hypothalamus. Activated microglia were found in close 
apposition to hypoglycemia-responsive NPY neurons. Inhibition of microglia by minocycline increased 
counterregulatory sympathetic response to hypoglycemia. Fractalkine-CX3CR1 signaling plays a 
role in control of microglia during hypoglycemia, because density and solidity of IBA1-ir profiles 
was attenuated in fasted, insulin-treated, CX3CR1 KO mice, which was parallel with exaggerated 
neuropeptide responses and higher blood glucose levels following insulin administration. Hypoglycemia 
increased Il-1b expression in the arcuate nucleus, while IL-1a/b knockout mice display improved 
glycemic control to insulin administration. In conclusion, activated microglia in the arcuate nucleus 
interferes with central counterregulatory responses to hypoglycemia. These results underscore 
involvement of microglia in hypothalamic regulation of glucose homeostasis.
Blood glucose concentration is under strict physiological control. Glucose levels falling below 3,5 mM provoke 
centrally integrated bodily responses to mobilize glucose from peripheral stores and increase gluconeogenesis 
aiming at restoration of normoglycemia1. Due to impaired autonomic counterregulatory responses (CRR), a seri-
ous condition, hypoglycemia associated autonomic failure (HAAF), may occur in diabetic patients2.
Glucose concentration is monitored by multiple peripheral and central glucosensors in the hypothalamus 
and brainstem3. These neurons are found in close surrounding of circumventricular organs, i.e. the median emi-
nence and the area postrema, through which additional metabolic-related hormonal- and nutritional signals are 
received4. Information in glucoregulatory control circuits then relayed to autonomic pre-ganglionic and neu-
roendocrine motor neurons, which regulate effectors such as chromaffin cells in the adrenal medulla, α and β 
cells in pancreatic islets and corticotropes/somatotropes in the anterior pituitary1. Hypoglycemia, as a potential 
life threatening condition, results activation of stress-related neurocircuit, which shares some common effectors 
involved in glucose counterregulatory responses (sympatho-adrenal activation and glucocorticoid secretion)5.
Metabolic- and stress-related circuits are intimately connected with immune regulation. Microglial cells 
are local representatives of the innate immune system in the CNS, which might be recruited in physiological 
responses to homeostatic challenges6,7. Microglia continuously screen tissue microenvironment via highly motile 
fine branches and become rapidly activated in response to subtle changes in synaptic activity or danger (damage)- 
and pathogen-associated molecular patterns (DAMPs and PAMPs)8,9.
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Increasing evidence support the involvement of glial elements in regulation, shaping and modulation adaptive 
physiological responses7. Along these lines, the aim of the present study was to investigate changes of hypotha-
lamic microglia in response to a strong homeostatic/metabolic challenge, hypoglycemia and to reveal the role of 
microglia in control of counterregulatory responses.
Results
Insulin injection to fasted mice results in hypoglycemia, activates hypothalamo-pitui-
tary-adrenocortical (HPA) axis and increases adrenaline and glucagon secretion. Single i.p. 
insulin injection to fasted C57BL/6 mice gradually decreased blood glucose levels to the 2.4 ± 0.2 mM minimum 
(hypoglycemia) at 60 min post-injection, then returned to the fasted baseline level by 240 min 4.02 ± 0.19 mM 
(Fig. 1A).
Based on this time course, all other measurements and comparisons were made at the 60 min time point.
One way ANOVA [F (2, 89) = 152.1, p < 0.0001] revealed significant difference between fed + vehicle; 
fasted + vehicle-injected and fasted + insulin treated groups at 60 min post-injection (Fig. 1B). Blood glucose 
levels in fed, vehicle-injected mice were 8.1 ± 0.29 mM, which decreased to 4.3 ± 0.2 mM after overnight fasting 
(Fig. 1B).
As a strong homeostatic stressor, hypoglycemia resulted in activation of HPA axis compared to fed [F (2, 
6) = 67.93, p < 0.0001; Bonferroni’s post hoc test, t(6) = 10.71, p < 0.001] and fasted [F (2, 6) = 67.93, p < 0.0001; 
Bonferroni’s post hoc test, t(6) = 8.3, p < 0.001] state as indicated by elevated corticosterone concentration 
(Fig. 1C). Hypoglycemia increased plasma adrenaline levels, although the difference between insulin treated 
(18.35 ± 3.58 ng/ml) vs. vehicle-injected groups (12.19 ± 1.92 ng/ml) was not statistically different (p > 0.05) 
(Fig. 1D). Hypoglycemia resulted in a marked elevation of plasma glucagon levels compared to vehicle-injected, 
fed control [F (2, 18) = 6.22, p = 0.009; Bonferroni’s post hoc test, t(18) = 4.66, p < 0.05] and fasted mice 
[Bonferroni’s post hoc test, t(18) = 3.64, p < 0.05](Fig. 1E).
Hypoglycemia activates stress-related and orexigenic neurons in the hypothalamus. Overnight 
fasting did not elevate c-fos mRNA levels in the whole hypothalamus compared to that of fed controls, while acute 
insulin-induced hypoglycemia significantly induced c-fos mRNA levels [F (2, 8) = 9.14, p = 0.009; Bonferroni’s 
post hoc test, t(8) = 4.27, p < 0.001] as measured by qPCR (Fig. 1F). Compared to fed and fasted controls, c-FOS 
induction was detected in the hypothalamic arcuate-, paraventricular nuclei (Fig. 1H) and in the lateral hypo-
thalamic area (Supplementary Fig. 4) in fasted, insulin-injected mice. Quantitative analysis of c-FOS positive cell 
nuclei confirmed significant hypoglycemia-induced increase in the paraventricular nucleus compared to fed [F 
(2, 6) = 10.05, p = 0.01; Bonferroni’s post hoc test, t(6) = 5.73, p < 0.05] and fasted mice [Bonferroni’s post hoc 
test, t(6) = 5.22, p < 0.05] (Fig. 1G,H). In the arcuate nucleus, fasting [F (2, 6) = 41.56, p < 0.001; Bonferroni’s post 
hoc test, t(6) = 7.06, p < 0.01] and fasting plus insulin treatment increased the number of c-FOS positive profiles 
compared to fed controls [Bonferroni’s post hoc test, t(6) = 8.53, p < 0.001] (Fig. 1G,H).
In order to reveal neuropeptide phenotype of hypoglycemia-activated neurons in the arcuate nucleus, double 
immune- and hybridization histochemical labeling approach was used (Fig. 2A). Combined in situ localization 
of Npy or Pomc mRNA with the activation marker, c-FOS in the medial basal hypothalamus revealed selective 
activation of orexigenic NPY neurons [t(11) = 38.86, p < 0.001]. 83% of all activated (c-FOS) positive neurons 
contained Npy mRNA, while only 4% of activated neurons expressed Pomc mRNA (Fig. 2B) in response to hypo-
glycemia. c-FOS and NPY protein colocalization was confirmed on brain sections from NPY-Ires-Cre ZsGreen 
reporter mice following overnight fasting and 1 h insulin injection (Fig. 2C).
Overnight fasting and fasting + insulin administration resulted in elevation of Npy [F (2, 8) = 9.93, p < 0.01] 
and Agrp mRNA levels in the hypothalamus [F (2, 8) = 12.01, p < 0.01]. As measured by RT-qPCR, Pomc mRNA 
expression remained unchanged between the groups (Fig. 2D).
Next, we checked if transcriptional changes in arcuate Npy neurons are translated to NPY protein. We did 
not find differences in density of NPY-immunoreactivity in the arcuate region of fed, fasted and fasted plus 
insulin-treated animals at 1 hour time point (Fig. 2E, Supplementary Fig. 2). Western blot analysis revealed a trend 
for increased hypothalamic NPY content in fasted and fasted + insulin treated mice (Fig. 2F,G, Supplementary 
Fig. 3).
Overnight fasting and insulin induced-hypoglycemia resulted in coexpression c-FOS and OREXIN-A in 
perifornical part of the lateral hypothalamus. Changes in Orexin-a mRNA levels (Relative fold change values: 
0,99 ± 0,17 in fasted-; 0,70 ± 0,07 in fasted + insulin) and number of OREXIN-A-ir cells (Supplementary Fig. 4) 
were not significant. MCH neurons in the lateral hypothalamus did not express c-FOS at any of these conditions 
(Supplementary Fig. 4).
Hypoglycemia results in morphological changes in hypothalamic microglia. Next, we investi-
gated if hypoglycemia activates microglia in the hypothalamus, using ionized calcium-binding adaptor molecule 
1 (IBA1) as microglia marker. In fed- and fasted, vehicle injected control animals, IBA1 immunostaining revealed 
predominantly resting form of microglia with moderate perisomatic immunoreactivity and fine branching pro-
cesses (Fig. 3A). By contrast, in the medial basal hypothalamus of fasted plus insulin-injected, hypoglycemic 
animals, microglia displayed activated phenotype with thickened branches and increased IBA1-ir (Fig. 3A). 
Analysis of IBA1 positive cells in arcuate nucleus revealed an increase (Fig. 3B) in hypoglycemic C57BL/6 mice 
compared to fed [F (2, 6) = 10.17, p < 0.05; post hoc test, t(6) = 4.24, p < 0.05], and fasted, vehicle treated mice 
[F (2, 6) = 10.17, p < 0.05; post hoc test, t(6) = 3.45, p < 0.05]. Hypoglycemia-induced microglia activation was 
confined to the arcuate nucleus: qualitative and quantitative analysis of IBA1 positive profiles in the hypothalamic 
paraventricular nucleus (Supplementary Fig. 5), hippocampus and cortex (Supplementary Fig. 6) did not reveal 
morphological signs of activation.
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Figure 1. Blood glucose levels, counterregulatory hormones, and neuronal activation in hypothalamus after 
overnight fasting and insulin-induced hypoglycemia in C57BL/6 mice. (A) Time course of blood glucose 
levels in fasted mice following i.p. insulin injection (1IU/kg) (n = 12 per blood sampling time). (B) Blood 
glucose levels in fed, fasted and fasted + insulin treated groups 1 hour after i.p. saline/insulin injection 
(n = 29–33 per group). (C–E) Hormonal responses to fasting and insulin-induced hypoglycemia. Elevation of 
plasma corticosterone (C) (n = 3–4), adrenaline (D) (n = 4-4) and glucagon (E) (n = 5–8 per group) plasma 
concentrations 1 h after insulin challenge. (F) Relative expression level of c-fos mRNA as measured by qRT-PCR 
in hypothalamus of fed, fasted, and fasted + insulin treated mice (n = 4 per group). (G) Counts of c-FOS-ir 
neurons in hypothalamic paraventricular (PVN) and arcuate (ARC) nuclei in fasted and fasted + insulin 
injected mice (n = 3 per group). (H) Representative photographs illustrating c-FOS expression in PVN and 
ARC after insulin-induced hypoglycemia. Scale bars, 50 µm; 3 V, third ventricle. Fed: fed, saline-injected 
group; Fasted: O/N fasted, saline-injected group; Fasted + insulin: O/N fasted, insulin-injected group. Data are 
expressed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 vs. fed; #p < 0.05, ##p < 0.01, 
###p < 0.001, ####p < 0.0001 vs. fasted.
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Figure 2. Hypoglycemia selectively activates orexigenic, NPY/AGRP -expressing neurons in hypothalamic 
arcuate nucleus (ARC). (A) Brightfield images of combined immunohistochemical (c-FOS; brown cell 
nuclei) and in situ hybridization histochemical [Npy or Pomc mRNA (black autoradiographic grains)] ARC 
preparations of fasted mice 1 h after insulin injection. Scale bars, 10 µm. (B) Colocalization of Npy or Pomc 
mRNA with c-FOS protein in ARC after insulin-induced hypoglycemia (n = 6–7). (C) Representative images of 
c-FOS (red) and NPY protein (green) colocalization in ARC of NPY-Ires-Cre ZsGreen reporter mice following 
insulin-induced hypoglycemia. (D) Expression of Npy, Agrp and Pomc mRNA in arcuate nucleus of fasted 
mice 1 h after insulin injection compared to fed and fasted, saline injected controls (n = 4 per groups). Fold 
change (FC) of mRNA expression was assessed by quantitative RT-PCR (qRT-PCR). (E) Quantitative analysis 
of NPY-immunostained hypothalamic sections of C57BL/6 mice. Bar graph represents the density of NPY-
immunreactivity (ir) in the unit area of arcuate nucleus (n = 3 per groups). (F,G) NPY levels, representative 
Western blot image (F) and quantification (G) from hypothalamus of fed, fasted and fasted + insulin injected 
mice (n = 3-3 per group). Full-length blot is presented in Supplementary Fig. 3. Fed: fed, saline-injected 
group; Fasted: O/N fasted, saline-injected group; Fasted + insulin: O/N fasted, insulin-injected group. All data 
expressed as mean ± SEM. *p < 0.05, **p < 0.01 vs. fed. 3 V: third ventricle.
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We next measured hypothalamic expression of select proinflammatory markers, which are related to activated 
microglia. Among these, hypothalamic expression of Il-1b mRNA was increased in hypoglycemic mice, compared 
to fed animals [t(5) = 3.54, p < 0.05]. mRNA levels of Il-1a, Il-6, Tnfa, Ccl2 (Mcp-1) and Ccl5 (Rantes) remained 
unchanged 1 hour after insulin (Fig. 3C). Iκb mRNA level was significantly elevated in the hypothalamus of 
fasted animals compared to fed [F (2, 8) = 7.02, p = 0.02; Bonferroni’s post hoc test, t(8) = 3.73, p < 0.05], but not 
to hypoglycemic (fasted + insulin injected) mice (Fig. 3C). Furthermore, Il-1ra mRNA level was decreased in 
fasted + insulin injected mice compared to fed animals [F (2, 8) = 4.58, p = 0.05; t(5) = 2.61, p < 0.05] (Fig. 3C).
Activated microglia make close appositions with c-FOS positive NPY neurons in the arcuate 
nucleus. Next, we investigated relation of microglia to hypoglycemia-responsive neurons in the arcuate 
nucleus. The “thickened” microglial cells were recruited around c-FOS+, activated neuron population in the ros-
tral and medial portion of the arcuate nucleus. Confocal imaging of triple fluorescent labeled material in fasted, 
insulin-injected CX3CR1+/gfp mice (microglia reporter strain on C57BL/6 background) revealed close apposi-
tion of microglia and hypoglycemia-activated, c-FOS positive neurons (Fig. 4A). Furthermore, similar contacts 
were found between NPY neurons and IBA1 positive microglia in hypoglycemic NPY reporter (NPY-Ires-Cre 
ZsGreen) mouse line (Fig. 4B).
Minocycline attenuates microglia activation in response to insulin and results in less severe 
hypoglycemic response. Next, we investigated whether inhibition of microglia affects glycemic response 
to insulin in fasted animals. Intracerebroventricular (i.c.v.) infusion of minocycline, an anti-inflammatory drug 
that impacts on microglial reactivity, attenuated insulin-induced microglia activation in the hypothalamus of 
fasted mice (Fig. 5A). The area of IBA1 positive cells was significantly smaller in the arcuate nucleus of minocy-
cline treated, fasted and insulin-injected mice compared to fasted, vehicle-injected controls [t(6) = 4.33, p < 0.01] 
(Fig. 5B). Number of IBA1 positive profiles in the arcuate nucleus was reduced following minocycline admin-
istration, however, the difference between vehicle-treated vs minocycline-treated animals was not significant 
(Fig. 5C). In fasted mice, microglia inhibition by minocycline resulted in 36% higher blood glucose level 1 h after 
insulin [t(8) = 2.87, p < 0.05] (Fig. 5D) compared to vehicle-injected, insulin-treated controls. Insulin-induced 
plasma adrenaline level was higher in minocycline-treated animals than in vehicle-treated mice [t(6) = 5.62, 
p < 0.05] (Fig. 5E). Npy mRNA expression in ARC, as measured by qRT-PCR, was not different (Fig. 5F).
Figure 3. Hypoglycemia recruits microglia in the hypothalamus. (A) Representative photomicrographs, 
showing ionized calcium-binding adaptor molecule 1 (IBA1) immunoreactive (-ir) microglia in ARC of fed, 
fasted and fasted + insulin-injected mice. Scale bars, 20 µm. 3 V: third ventricle, ME: median eminence. (B) 
Mean ± SEM percentages of the area covered by IBA1-immunoreactivity per unit area in ARC (n = 3 per 
group). ROIs are shown on images. (C) Mean ± SEM values of relative mRNA levels of proinflammatory 
cytokines (Il-1a Il-1b, Il-6, Tnfa) chemokines (Ccl2, Ccl5) and IκB, Il-1ra in hypothalamus (n = 4 per groups). 
Fed: fed, saline-injected group; Fasted: O/N fasted, saline-injected group; Fasted + insulin: O/N fasted, 
insulin-injected group. All data on the figure expressed as mean ± SEM. *p < 0.05 vs. fed; #p < 0.05 vs. fasted as 
determined by Bonferroni post hoc test.
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Minocycline administration did not significantly affect resting appearance of microglia in PVH, LH, hip-
pocampus and cortex (Supplementary Fig. 6).
Fractalkine receptor (CX3CR1) deficient mice mount increased counterregulatory responses to 
insulin-induced hypoglycemia and neuroglycopenia. Fractalkine receptor is critically implicated in 
activation of microglia in response to physiological and traumatic insults. Next, we compared effects of insulin 
injections to fasted, wild type and fractalkine receptor deficient mice. In these animals, second exon of the Cx3cr1 
gene has been replaced by Egfp (CX3CR1 gfp/gfp = CX3CR1−/− on C57BL/6 background10). Qualitative and quan-
titative analysis of IBA1 positive microglia revealed significant effects of insulin treatment in the ARC (Fig. 6A–
E). Area covered by IBA1 immuno-labelled profiles (Fig. 6B) [F (1, 8) = 49.88, p < 0.001], and solidity of IBA1 
positive cells increased significantly (Fig. 6D) [F (1, 8) = 6.62, p = 0.03]. Insulin treatment had no effect on the 
number of microglial cells. Bonferroni’s multiple comparison test indicated significantly smaller area occupied 
by IBA1 immuno-reactive cells (Fig. 6B) in ARC of fasted, insulin treated, fractalkine receptor deficient animals, 
than in similarly treated, C57BL/6 animals [t(8) = 5.03, p < 0.05]. The nearest neighbor distance between micro-
glial cells in the ARC decreased significantly after insulin injection [F (1, 43) = 20.6, p < 0.0001] (Fig. 6C). C-FOS 
immunostaining revealed a trend for increased neuronal activation in hypoglycemic CX3CR1−/− mice compared 
to wild-type mice (Fig. 6E).
Wild-type and CX3CR1−/− mice displayed similar blood glucose levels in fed and fasted states, however fasted 
CX3CR1−/− mice did not develop hypoglycemia in response to insulin [blood glucose in C57BL/6: 2,02 ± 0,13 mM 
vs. CX3CR1−/−: 3,58 ± 0,45 mM; t(8) = 2.54, p = 0.035] (Fig. 7A).
Systemic administration of 2-deoxy-D-glucose (2-DG) resulted in counterregulatory increase in blood glucose 
levels in fed mice [F (1, 11) = 80.19, p < 0.0001]. 1 h following 2-DG, plasma glucose levels in CX3CR1−/− animals 
Figure 4. Microglia make close appositions with hypoglycemia-activated neurons in arcuate nucleus. (A) 
Confocal imaging of triple fluorescent-labeled section from ARC of hypoglycemic CX3CR1 +/gfp microglia 
reporter mouse. GFP (green) –microglia; c-FOS (red) –cell nuclei of activated neurons; and neurofilament 
H (NF-H) (blue) – neurons. (B) Representative images of contacts between NPY neurons (green) and IBA1 
positive microglia (red) in hypoglycemic NPY-Ires-Cre ZsGreen reporter mouse line. The appositions between 
microglia and NPY neurons were revealed in the arcuate nucleus by using merged confocal Z-stack images with 
orthogonal views XZ and YZ, at 60x magnification. White arrows mark close appositions between microglia 
and NPY neurons.
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were significantly higher than those of C57BL/6 mice [F (1, 11) = 38.83, p < 0.0001; Bonferroni’s post hoc test, 
t(11) = 6.65, p < 0.0001] (Fig. 7B).
To rule out the possibility of insulin insensitivity in CX3CR1−/− mice, we performed insulin tolerance tests 
in both genotypes. Initial decline of glucose levels in fasted animals following insulin injection (Fig. 7C) and the 
area under the glucose curve (AUC) did not reveal significant differences in insulin sensitivity between wild type 
and CX3CR1−/− mice (AUC: C57BL/6: 982 mM/240 min vs. CX3CR1−/− :1044 mM/240 min). We did not detect 
significant differences in glucose tolerance between the two genotypes (Supplementary Fig. 7).
Fractalkine receptor deficient mice mounted significantly increased plasma adrenaline response following 
insulin compared to vehicle-treated fed controls [F (1, 10) = 9.98, p = 0.01; Bonferroni’s post hoc test, t(10) = 2.75, 
Figure 5. Manipulation of microglia affects glycemia and counterregulatory response to hypoglycemia. (A) 
Photomicrographs showing IBA1-ir microglia in arcuate nucleus of vehicle- or minocycline treated, fasted mice 
1 h following insulin administration. Scale bar: 20 µm; 3V-third ventricle. (B) Area covered by IBA1-ir profiles 
expressed as percentage of the unit arcuate area (n = 5-5). (C) Number of IBA1-ir ARC cells in fasted + insulin 
injected mice, pretreated i.c.v. vehicle or minocycline (n = 5-5). (D) Blood glucose levels of fasted + insulin-
treated mice, which were pretreated either with minocycline or vehicle i.c.v. Note that inhibition of microglia 
activity attenuated the drop of blood glucose following insulin injection (n = 5-5). (E) Plasma adrenaline 
levels in minocycline or vehicle-pretreated, fasted animals following insulin treatment (n = 3-3). (F) Relative 
hypothalamic Npy mRNA expression in minocycline or vehicle-pretreated animals following O/N fasting and 
insulin administration, measured by qRT-PCR (n = 3-3). All data expressed as mean ± SEM. In all graphs, 
*p < 0.05, **p < 0.01 (two-sided t-test).
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p < 0.05] (Fig. 7E). However, genotype did not influence hypoglycemia-induced plasma corticosterone [F (1, 
11) = 0.01, p = 0.93] (Fig. 7D), and glucagon responses [F (1, 23) = 1.05, p = 0.32] (Fig. 7F).
As shown on Fig. 7H,I fasted, insulin-treated, CX3CR1−/− mice displayed significantly higher hypothalamic 
Npy [F (1, 12) = 30.28, p < 0.001; Bonferroni’s post hoc test, t(12) = 8.60, p < 0.001] and Agrp [F (1, 12) = 31.61, 
p < 0.001; Bonferroni’s post hoc test, t(12) = 8.34, p < 0.001] mRNA response than wild-type animals. Pomc levels 
in ARC remained unchanged in both genotypes. Co-localization of c-FOS immunoreactivity with Npy or Pomc 
mRNA revealed preferential activation of NPY neurons. Furthermore, higher number of double stained profiles 
was found in fasted insulin treated, CX3CR1−/− animals compared to fasted, insulin treated wild-type [F (1, 
23) = 7.87, p = 0.01; Bonferroni’s post hoc test, t(23) = 3.33, p < 0.001] (Fig. 7G).
Danger signals provoke release of proinflammatory cytokines, such as IL-1 from activated glial cells. We found 
increased Il-1b mRNA level in hypothalamic blocks of control, C57BL/6 mice in response to insulin-induced 
hypoglycemia [F (1, 8) = 21.60, p < 0.01; Bonferroni’s post hoc test, t(8) = 4.93, p < 0.001]. By contrast, 
hypoglycemia-induced increase of Il-1b mRNA was not seen in mice with impaired fractalkine signaling between 
neurons and microglia [Bonferroni’s post hoc test, t(8) = 1.65, p > 0.05]. (Fig. 8A).
To assess the impact of IL-1 in organization of glucose responses hypoglycemia, IL-1 a/b KO mice were chal-
lenged with insulin. We found that IL-1 a/b KO mice displayed higher blood glucose concentration in response 
to insulin administration than wild type controls [main effect of genotype: F(1,12) = 5.02, p = 0.045], their blood 
glucose concentration did not decrease below 3 mM (Fig. 8B). In response to 2-DG, IL-1 a/b KO mice have 
higher glucose levels (18.04 ± 2.23 mM) compared to wild type controls (14.70 ± 2.03 mM), however the differ-
ence between 2-DG-treated groups was not significant (data not shown).
Discussion
Here we show that insulin-induced hypoglycemia selectively activates microglia in the hypothalamic arcu-
ate nucleus and this microglial activation likely attenuates full expression of counterregulatory responses to 
hypoglycemia.
Hypoglycemia occurs quite often in patients with insulin resistance, type 1 and even type 2 diabetes after 
insulin treatment and/or following intense exercise. Furthermore, hypoglycemia associated autonomic fail-
ure (HAAF) in diabetic patients is a serious condition in which antecedent hypoglycemia results in impaired 
Figure 6. Neuron-microglia communication is critical for microglia activation in insulin-induced 
hypoglycemia. (A) Photomicrographs showing c-FOS (black cell nuclei) and IBA1-ir profiles (brown) in arcuate 
nucleus of wild-type and fractalkine receptor deficient (CX3CR1−/−), fed + vehicle treated and fasted + insulin-
treated mice. Note microglia accumulation close to c-FOS expressing neurons in wild-type, fasted + insulin 
treated animals. Scale bar: 20 µm; 3 V: third ventricle. (B–D) Quantitative analysis of microglia population 
in arcuate nucleus (n = 3 per groups). (B) Area % occupied by IBA1 positive profiles; (C) Nearest neighbor 
distance; (D) Solidity index; (E) Number of c-FOS positive cells in arcuate nucleus of wild-type and CX3CR1−/−, 
fed or fasted + insulin-treated mice (n = 3 per group). Mean ± SEM values. Two way ANOVA: significant 
treatment effect indicated by #p < 0.05, ###p < 0.001, ####p < 0.0001 and genotype effect indicated by **p < 0.01. 
Fed: fed, saline-injected group; Fasted + Insulin: O/N fasted, insulin-injected group.
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autonomic counterregulatory responses (CRR). Therefore, identification of confounding factors that affect organ-
ization of a normal CRR is important.
Here, selective activation of arcuate orexigenic neurons and rapid increase of Npy/Agrp gene expression have 
been revealed in hypoglycemic mice. This effect was found to be specific for orexigenic neurons, since Pomc 
expressing medial basal hypothalamic (MBH) neurons do not express c-FOS in response to decrease in plasma 
glucose. These findings are consistent with those reported by Muroya et al.11 and Fioramonti et al.12. Arcuate NPY 
neurons play an essential role in driving counterregulatory responses to hypoglycemia because: (1) subset these 
cells are glucosensitive/glucose inhibited12; (2) Npy expression is rapidly upregulated in response to hypoglyce-
mia13; (3) NPY fibers originating in the arcuate nucleus densely innervate preautonomic neurons in the hypotha-
lamic paraventricular nucleus and intermediolateral cell column of the spinal cord, which provide sympathetic 
output to the liver, pancreas and adrenal medulla14,15 and (4) NPY mediates fasting-induced sympatho-adrenal 
synaptic plasticity and adrenaline release, which is important to maintain euglycemia16.
Figure 7. Neuron-microglia communication through fractalkine receptor is critical in organization of 
counterregulatory response to insulin-induced hypoglycemia and 2-deoxy glucose-induced neuroglycopenia 
(A) Blood glucose levels in fed, fasted, fasted + insulin-injected, wild-type and fractalkine receptor deficient 
(CX3CR1−/−) mice (n = 5–20). (B) Comparison of blood glucose responses in fed, wild-type and CX3CR1−/− 
mice to neuroglycopenia induced by i.p. injection of 2-deoxyglucose (2-DG, 200 mg/kg) or vehicle. (C) Blood 
glucose levels in response to i.p. insulin injection (1IU/ml/kg bw) during insulin tolerance test (n = 12 per 
groups) (D–F) Mean ± SEM values of plasma corticosterone (D); adrenaline (E) and glucagon (F) levels 
in fed and fasted + insulin-treated, wild-type and CX3CR1−/− mice (n = 3–8). (G) Quantitative analysis of 
hypoglycemia-responsive Npy and Pomc neurons. Values obtained from fasted + insulin-injected, wild- type 
and CX3CR1−/− mice (n = 6–8) and expressed as percentage of double labeled cells relative to all c-FOS positive 
neurons in the arcuate nucleus. (H,I) Hypothalamic Agrp and Npy mRNA levels in fed and fasted + insulin-
treated, wild-type and CX3CR1−/− mice (n = 4–4) as measured by qRT-PCR. Two-way ANOVA followed by 
Bonferroni’s post-hoc test revealed significant treatment effect indicated by #p < 0,05, ##p < 0,01, ####p < 0,0001 
or genotype effect indicated by *p < 0.05, ****p < 0.0001. Fed: fed, saline-injected group; Fasted: O/N fasted, 
saline-injected group; Fasted + insulin: O/N fasted, insulin-injected group.
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In addition to activation of hypothalamic NPY/AGRP neurons, microglia in the arcuate nucleus become 
activated in hypoglycemic animals as revealed by set of morphometrical measures in IBA1 stained material. 
First, activation of microglial cells was revealed by the increase of IBA1 stained area within the arcuate nucleus. 
Detailed spatial and morphological analysis showed that hypoglycemia elicited an increase of soma size and 
a decrease of the area occupied by microglia processes (solidity), corresponding to the accepted hallmarks of 
microglial responses to diverse activating stimuli17. Furthermore, an increase of the number of IBA1-ir profiles in 
hypoglycemic animals also implicates changes in microglial activity in response to physiological threat.
Activation of microglia following exposure emotional stressors is widely observed18–20, however, much less is 
known about the effects of physiological stressors on microglia21. Here, hypoglycemia-induced microglia acti-
vation was confined to the medial basal hypothalamus/arcuate nucleus/median eminence region and not seen 
in any other extrahypothalamic or limbic structures. By contrast, a study in rats revealed significant increase of 
CD11b positive microglia in the hippocampus following sustained and severe hypoglycemia (up to isoEEG), 
which was rather due to neuronal death following glucose reperfusion, but not to directly to the decrease of blood 
glucose22.
The critical involvement of microglia activation in hypoglycemia was assessed by minocycline, a second 
generation tetracycline, which inhibits microglia activation and has an anti-inflammatory action19. Based on 
morphological measures, minocycline administration attenuated insulin-induced microglia activation in the 
arcuate nucleus, which was accompanied with improved glycemic control, elevated plasma catecholamine lev-
els and less severe hypoglycemia. This finding is consistent with reports of protective effects of minocycline on 
hypoglycemia-induced neuronal death and cognitive impairment23.
It is not likely that microglial cells are directly responsive to glucose deprivation, however, fasting and hypo-
glycemia results in acidic extracellular microenvironment, which might favor microglia activation through acid 
sensing receptors (ASICs and TDAG8)21,24. Furthermore, alarmins such as secreted extracellular heat shock pro-
tein (eHSP72)25, mtDNA fragments26 and HMGB127,28 or ATP9 might be among the factors driving microglial 
sensitization/activation/sterile inflammation29 during hypoglycemia.
Confocal microscopic analysis of hypothalamic sections revealed that IBA1 positive microglia are recruited in 
close apposition to hypoglycemia-activated c-FOS positive, NPY neurons. This observation is comparable to that 
reported by Sugama et al. where microglial activation occurred adjacent to stress-responsive neurons in the peri-
aqueductal gray (PAG) of restrained rats30. Such microglial arrangement suggests the involvement of signals orig-
inating in activated (c-FOS positive) neurons. Among neuronal signals which control microglia function, the role 
of fractalkine is emerging. Fractalkine is a CX3C chemokine expressed by neurons or activated astrocytes, which 
controls microglia executive functions upon binding to its unique receptor (CX3CR1) on microglia10. Indeed, 
CX3CR1−/− mice with impaired neuron-to-microglia communication did not display overt microglia activation 
and did not develop hypoglycemia in response to insulin challenge. This is very likely due to their improved coun-
terregulatory responses such as increased hypothalamic NPY/AGRP expression and sympathomedullary and 
adrenomedullary hormone secretion. Nonetheless, the role of additional neuronal factors regulating microglia 
activity, such as the complement factor C3 or CD200 might also play some role31,32.
In addition to hypothalamus, cells responding specifically to hypoglycemia have been found in the dorsal 
vagal complex, including the nucleus of the solitary tract, dorsal motor nucleus of the vagus and related circum-
ventricular organ, area postrema5,33 as well as in catecholaminergic neurons of the ventrolateral medulla34,35. 
Figure 8. Proinflammatory cytokine IL-1 is associated with insulin-induced hypoglycemia. (A) Relative 
quantities of hypothalamic Il-1b mRNA of fed and fasted + insulin-injected, wild-type and CX3CR1−/− mice 
(n = 3 per groups). (B) IL-1 a/b knockout animals do not display severe hypoglycemia in response to insulin 
challenge as do wild type animals. Mean ± SEM blood glucose levels in fed and fasted + insulin treated, wild-
type and IL-1 a/b KO mice, 1 h after i.p. injections (n = 3–5). Two-way ANOVA with Bonferroni post hoc test 
revealed main treatment effect of ##p < 0.01; main genotype effect: *p < 0.05, **p < 0.01, ***p < 0.001. Fed: fed, 
saline-injected group; Fasted + Insulin: O/N fasted, insulin-injected group.
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Because these areas also display c-FOS induction in hypoglycemic animals, activation of hindbrain microglia and 
their recruitment in glycemic control remains to be elucidated.
Among the factors released by activated microglia, interleukin IL-1 is major cytokine secreted upon physio-
logical and/or stress challenges8,21. IL-1b causes hypoglycemia36,37 acting centrally to reset glucose homeostasis38. 
To support the involvement of IL-1 in modulation of hypoglycemia-induced counterregulatory responses, we 
showed that mice lacking both IL-1a and b (IL-1a/b KO) displayed less severe insulin-induced hypoglycemia 
than wild type controls.
It should be noted, however that microglia might not be the only central source of IL-1 in hypoglycemic 
stressed animals. There are reports showing reactive astrocytes and even activated neurons to be able to synthesize 
IL-139. We showed an increase of GFAP+ profiles in ARC of insulin injected wild-type and fraktalkine receptor 
deficient mice (Supplementary Fig. 8). Furthermore, additional cytokines, such as TNFa and IL-6 might also be 
involved in hypoglycemia37. By contrast, we did not find significant increases of these cytokines at 1 hour time 
point at the mRNA level.
It should  also be noted that some of these effects might be due to parallel changes occurring at the periphery. 
For instance, hypoglycemia increases leukocyte counts and circulating levels of pro-inflammatory cytokines40, 
which act directly in the liver inhibiting gluconeogenesis37 or in the pancreas increasing endogenous insulin 
secretion. IL-1 increases glucose uptake and consumption at the periphery. Because both knockouts (CX3CR1−/− 
and IL-1a/b KO) are not cell type specific, the reported microglia associated glucoregulatory changes are supple-
mented with actions mediated through peripheral monocytes and macrophages. Recently, fractalkine-CX3CR1 
system has been implicated in the direct regulation of pancreatic islet function. Long acting fractalkine analogue 
reduced glucagon secretion and enhanced hepatic insulin sensitivity41. There is a possibility that differences in 
blood glucose levels seen in CX3CR1−/− and IL-1a/b KO mice compared to WT following insulin administration 
are rather due to insulin resistance than impaired counterregulatory responses. To rule out this possibility, we 
performed insulin tolerance test in both genotypes and did not find overt differences in insulin sensitivity. We 
also used 2-DG, a non-metabolizing glucose analogue, which results in neuroglucopenia and provoke physio-
logical counterregulatory responses. Importantly, both CX3CR1−/− and IL-1a/b KO mice displayed improved 
glucoregulatory response to 2-DG as well, suggesting unrestrained CRR, not insulin insensitivity.
Collectively, our data show, for the first time, that acute hypoglycemia selectively activates hypothalamic 
microglia. These microglial cells are found in close apposition with orexigenic NPY/AGRP neurons in the arcuate 
nucleus. Attenuation of microglia activation results in improved counterregulatory responses to glucopenia and 
less severe insulin-induced hypoglycemia.
Methods
Experimental animals. All animal procedures were conducted in accordance with the European 
Communities Council Directive (86/609 EEC) and the Hungarian Act of Animal Care and Experimentation 
(1998; XXVIII, Sect. 243/1998), approved by the Animal Care and Use Committee of the Institute of Experimental 
Medicine, Hungarian Academy of Sciences (permit number: PEI/001/29-4/2013).
Experiments were performed on adult male C57BL/6 J, CX3CR1−/− 10 CX3CR1+/−, IL-1 a/b KO42 and 
BAC-NPY/Cre//Gt (ROSA)26Sor_CAG/LSL_ ZsGreen1 mice (on C57BL/6 background).
Mice were group housed and maintained under controlled conditions (temperature: 22 ± 2 °C; humidity: 65%; 
lighting schedule: 07:00-19:00) with food and water available ad libitum unless otherwise stated.
Insulin-induced hypoglycemia. Mice starved overnight (18 h) and injected intraperitoneally (i.p.) with 
1IU/ml/kg bw insulin (Actrapid, Novo Nordisk). Blood glucose levels were measured by DCont Personal Blood 
Glucose Meter (77 Elektronika Kft. Hungary) from samples of trunk blood or tail snip. Control fed and fasted 
mice were injected i.p. with sterile saline.
Intracerebroventricular (i.c.v.) injections. Mice were anesthetized with a cocktail of 100 mg/kg ketamine 
and 10 mg/kg xylazine (1 ml/100 g bw, i.p.) and the right lateral cerebral ventricle was approached by a stainless 
steel cannula at the following coordinates: A-P: −0,05 mm; L: −0,11 mm; D-V-0,2 mm. Mice were injected i.c.v. 
with 20 µg minocycline hydrochloride (M-9511, Sigma) in 2 µl saline. After injection, mice were fasted overnight 
and injected intraperitoneally (i.p.) with minocycline (50 mg/kg, 10 ml/kg) and with 0.8 IU/kg insulin 1 h before 
sacrifice.
Glucoprivation. Male C57BL/6 J controls CX3CR1−/−, and IL-1 a/b KO mice were injected i.p. with 
2-deoxyglucose (Sigma D8375; dose: 200 mg/kg bw) and were decapitated 1 h after injection for blood glucose 
analysis.
plasma hormone levels. Plasma corticosterone was measured by direct RIA as described43.
Plasma catecholamines (2-CAT, Labor Diagnostika Nord, Germany) and glucagon (Crystalchem, USA) were 
measured by ELISA according to the manufacturer’s instructions. For adrenaline and noradrenaline measure-
ment extraction steps were performed before ELISA as instructed.
Perfusion, tissue processing and immunohistochemistry. For histology, mice were anesthetized and 
perfused with ice cold fixative (4% paraformaldehyde in 0.1 M phosphate buffer pH 7.2). Four complete series of 
coronal sections (20 µm) were cut on freezing microtome and stored in cryoprotectant at −20 °C. Single-, double- 
and triple immunohistochemistry was done as described in43. Detailed protocols and analysis are found in the 
Supplemental Material.
In situ hybridization histochemistry was performed according to the protocols described in44 and modified by45 
(for details see Supplementary Material).
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Imaging and c-FOS quantification. One complete series of sections (4 × 25 µm = 100 µm apart) were 
stained for each antigens. Digital images of hypothalamic paraventricular nucleus (PVN) (between bregma −0.58 
and −0.94), and arcuate nucleus (ARC) as46 (between bregma −1.22 and −1.94) in C57BL/6 and CX3CR1−/− 
mice were captured 20x magnification by Spot RT color digital camera (Diagnostic Instruments Inc., IL, USA) 
on Nikon Eclipse 6000 microscope. Images were then re-opened in Image J 1.48 software and set at a common 
threshold to subtract the background optical density. The software automatically counted the number of immu-
noreactive cell nuclei (c-FOS) within the region of interest (ROI). 3–4 sections per animal containing the ROI 
were used in the analysis (n = 3–5 mice).
Analysis of microglia. To determine the area, the number, the distribution and morphological parameters 
of Iba1 + microglia, we used Microglia Analyzer, a MATLAB based, custom-designed software (K. Gulyás43). 
Quantification of Iba1+ cells were performed in the ROI using unit area square selection in the ARC or PVN area. 
The images were converted into a binary black-and-white format. An automated count of white pixels (represent-
ing all IBA1+ signals) was applied and the IBA1 staining was reported as percentage of unit area.
The convex area (CA) is the area of the smallest convex polygon drawn around the microglial cell by con-
necting the furthest points of its processes. The solidity index is calculated by dividing the area of the microglia 
(IBA1+) cell by its convex area (CA). The more ramified, thinner microglia, the bigger convex area is, thus yield-
ing a smaller solidity index. Higher solidity values are characteristic of activated microglia, having thickened and 
shortened processes and smaller convex area (Supplementary Fig. 1).
Distribution of microglia in the ARC was characterized by the nearest neighbor distance (NND)43. For this 
calculation, the X-Y coordinates for each microglia were recorded at the region of interest. The Euclidean distance 
between each microglia and its nearest neighbor (NND) was calculated in Microglia Analyzer software. This 
value was then averaged for all images to define the value per animal.
Quantitative real-time pCR. Total RNA was isolated from arcuate nucleus samples with QIAGEN 
RNeasyMiniKit (Qiagen, Valencia, CA, USA) according the manufacturer’s instruction. To eliminate genomic 
DNA contamination, DNase I (Fermentas) treatment was used. Sample quality control and the quantitative anal-
ysis were carried out by NanoDrop (Thermo Scientific). Amplification was not detected in the RT-minus controls. 
cDNA synthesis was performed with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster 
City, CA, USA). Designed primers (Invitrogen) were used in real-time PCR reaction with Power SYBR Green 
PCR master mix (Applied Biosystems, Foster City, CA, USA) on ABI StepOnePlus instrument. The amplicon 
was tested by Melt Curve Analysis and mRNA levels were calculated by ABI StepOne 2.3 program using ΔΔCT 
method. Experiments were normalized to GAPDH expression. Primer sequences are listed in Supplemental 
Material.
Western blot. After decapitation, whole hypothalamic samples were dissected and immediately frozen 
at −70 °C. Total protein from tissue homogenates was isolated with Geneaid PrestoTM DNA/RNA/Protein 
Extraction Kit (Geneaid) according to the manufacturer’s instruction. Protein content was measured by PierceTM 
BCA Protein Assay Kit (ThermoFisher Scientific). After denaturation, samples were separated on 12% sodium 
dodecyl sulphate - polyacrylamide gel electrophoresis (SDS-PAGE). Immunoblotting was performed to pol-
yvinylidene difluoride (PVDF) membranes (Millipore) using semi-dry transfer (Trans Blot SD Cell, Biorad). 
Non-specific binding was blocked in 5% BSA (Sigma) for 1 h. After incubation, PVDF membrane was cut 
between 42kDA and 17 kDa marks according to the protein ladder (Benchmark pre-stained protein ladder, 
Invitrogene). Membranes were incubated in anti-b-ACTIN (1:5000, Sigma) or rabbit anti-NPY (1:1000, cour-
tesy Dr. R. Corder, Geneva Switzerland) primary antibodies, respectively at 4 °C overnight. This was followed by 
incubation in respective biotinylated secondary antibodies (1:1000, Vector Labs) and then in avidin-biotin-HRP 
complex (1:250, Vector Labs) for 1–1 h. Membranes were developed by immunoperoxidase reaction and analyzed 
by UVITec Q9 Alliance© software.
statistical analysis. Data are presented as mean ± standard deviation (SD) and were analyzed by one-way 
ANOVA (in case of three different groups) or two-way ANOVA with Bonferroni post hoc test using GraphPad 
Prism software (ver. 6.01; San Diego, CA, USA). On the figures, * marks genotype difference, # marks treatment 
effects. To analyze differences between two group means, unpaired or paired two sided t-test was performed. In 
all cases, p-value < 0.05 was considered statistically significant.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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